These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 7848013

  • 1. Antihypertensive effects of a new transdermal delivery system for clonidine (M-5041T) in spontaneously hypertensive rats.
    Ishii R, Naruse T, Tagawa T, Yamahata T, Dote S, Hamada K, Ishida T, Funabiki K, Namba K.
    Arch Int Pharmacodyn Ther; 1994; 327(3):294-308. PubMed ID: 7848013
    [Abstract] [Full Text] [Related]

  • 2. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R, Tagawa T, Ishida T, Naruse T.
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [Abstract] [Full Text] [Related]

  • 3. Hypotensive effects of a new transdermal delivery system for clonidine (M-5041T) in spontaneously and renal hypertensive rats.
    Ishii R, Naruse T, Tagawa T, Ishida T, Namba K.
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S374-6. PubMed ID: 9072434
    [Abstract] [Full Text] [Related]

  • 4. Preclinical assessment of a new transdermal delivery system for clonidine (M-5041T).
    Naruse T, Ishida T, Ishii R, Tagawa T.
    Fundam Clin Pharmacol; 1996 Dec; 10(1):47-55. PubMed ID: 8900500
    [Abstract] [Full Text] [Related]

  • 5. Effect of clonidine on tyrosine hydroxylase activity in the adrenal medulla and brain of spontaneously hypertensive rats.
    Moura E, Afonso J, Serrão MP, Vieira-Coelho MA.
    Basic Clin Pharmacol Toxicol; 2009 Feb; 104(2):113-21. PubMed ID: 19067675
    [Abstract] [Full Text] [Related]

  • 6. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI, Hofferber E, Stenzel W.
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [Abstract] [Full Text] [Related]

  • 7. Differential blood pressure responses to intracisternal clonidine, alpha-methyldopa, and 6-hydroxydopamine in conscious normotensive and spontaneously hypertensive rats.
    Head GA, de Jong W.
    J Cardiovasc Pharmacol; 1986 Oct; 8(4):735-42. PubMed ID: 2427812
    [Abstract] [Full Text] [Related]

  • 8. Changes in plasma and urinary norepinephrine following transdermal clonidine in spontaneously hypertensive rats.
    Ishii R, Furuta M, Hashimoto M, Tagawa T, Naruse T, Hata T.
    Arzneimittelforschung; 1998 Aug; 48(8):811-7. PubMed ID: 9748708
    [Abstract] [Full Text] [Related]

  • 9. Differences in the ability of yohimbine to antagonize the hypotensive effect of clonidine in normotensive and spontaneously hypertensive anesthetized rats.
    Tibirica E, Feldman J, Bousquet P.
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1062-6. PubMed ID: 2855238
    [Abstract] [Full Text] [Related]

  • 10. Absence of tolerance to hypotensive effects of clonidine in spontaneously hypertensive rats.
    Naruse T, Ishii R, Tagawa T.
    Jpn J Pharmacol; 1995 Apr; 67(4):407-410. PubMed ID: 7650877
    [Abstract] [Full Text] [Related]

  • 11. Role of brain cholinergic system in the antihypertensive effect of clonidine in different models of rat hypertension.
    Squadrito F, Quattrone G, Buemi M, Frisina N, Caputi AP, Squadrito G.
    J Hypertens Suppl; 1985 Dec; 3(4):S97-9. PubMed ID: 3868718
    [Abstract] [Full Text] [Related]

  • 12. Effects of a newly developed transdermal clonidine delivery system (M-5041T) on EEG sleep-wake cycle in relation to plasma concentration in rabbits.
    Kimura K, Ishihara K, Tagawa T, Sakurai M, Fujii Y, Dote S, Naruse T, Sasa M, Namba K.
    Gen Pharmacol; 1996 Jan; 27(1):73-7. PubMed ID: 8742497
    [Abstract] [Full Text] [Related]

  • 13. On the relationship between clonidine hypotension and brain beta-endorphin in the spontaneously hypertensive rat: studies with alpha adrenergic and opiate blockers.
    Mastrianni JA, Ingenito AJ.
    J Pharmacol Exp Ther; 1987 Jul; 242(1):378-87. PubMed ID: 3039113
    [Abstract] [Full Text] [Related]

  • 14. [The effects of intrathecal clonidine in spontaneously hypertensive rats].
    Fukuda T, Naito H.
    Masui; 1994 Jan; 43(1):64-9. PubMed ID: 8309057
    [Abstract] [Full Text] [Related]

  • 15. Possible role of an endogenous opiate in the cardiovascular effects of central alpha adrenoceptor stimulation in spontaneously hypertensive rats.
    Farsang C, Ramirez-Gonzalez MD, Mucci L, Kunos G.
    J Pharmacol Exp Ther; 1980 Jul; 214(1):203-8. PubMed ID: 6248627
    [Abstract] [Full Text] [Related]

  • 16. [Blocking by naloxone of the antihypertensive effect of clonidine in hypertensive and normotensive animals].
    Val'dman AV, Medvedev OS, Rozhanskaia NI.
    Biull Eksp Biol Med; 1981 Nov; 92(11):560-2. PubMed ID: 7317633
    [Abstract] [Full Text] [Related]

  • 17. Hypothalamic microinjection of alpha 2-adrenoceptor agonists causes greater sympathoinhibition in spontaneously hypertensive rats on high NaCl diets.
    Wyss JM, Yang RH, Jin HK, Oparil S.
    J Hypertens; 1988 Oct; 6(10):805-13. PubMed ID: 2848885
    [Abstract] [Full Text] [Related]

  • 18. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
    Narita H, Murata S, Yabana H, Kikkawa K, Sugawara Y, Akimoto Y, Nagao T.
    Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M, Matsumura S, Masui M, Matsuura E, Kawakami M, Fujitomo H, Umeda T, Kagawa H, Hirohata S, Shima K.
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [Abstract] [Full Text] [Related]

  • 20. Hypotensive and hemodynamic effects of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
    Shirota M, Iijima M, Ushijima T, Kajiwara Y, Kitabatake K.
    Arzneimittelforschung; 1990 Dec; 40(12):1303-9. PubMed ID: 2095126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.